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ABSTRACT 
Detection of enzyme biomarkers originating from either bio-fluids or contaminating microorganisms is of utmost importance in clinical diagnostics 
and food safety. Herein, we present a simple, low-cost and easy-to-use sensing approach based on the switchable peroxidase-mimicking 
activity of plasmonic gold nanoparticles (AuNPs) that can catalyse for the oxidation of 3,3’,5’5-tetramethylbenzidine (TMB) for the determination 
of protease enzyme. The AuNP surface is modified with casein, showing dual functionalities. The first function of the coating molecule is to 
suppress the intrinsic peroxidase-mimicking activity of AuNPs by up to 77.1%, due to surface shielding effects. Secondly, casein also functions 
as recognition sites for the enzyme biomarker. In the presence of protease, the enzyme binds to and catalyses the degradation of the coating 
layer on the AuNP surface, resulting in the recovery of peroxidase-mimicking activity. This is shown visually in the development of a blue 
colored product (oxidised TMB) or spectroscopically as an increase in absorbance at 370 and 650 nm. This mechanism allows for the detection 
of protease at 44 ng·mL−1 in 90 min. The nanosensor circumvents issues associated with current methods of detection in terms of ease of 
use, compatibility with point-of-care testing, low-cost production and short analysis time. The sensing approach has also been applied for the 
detection of protease spiked in ultra-heat treated (UHT) milk and synthetic human urine samples at a limit of detection of 490 and 176 ng·mL−1, 
respectively, showing great potential in clinical diagnostics, food safety and quality control. 
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1 Introduction 
The sensitive and rapid detection of enzymes can reveal the early 
onset of infection [1], inflammation [2], or contamination [3] and 
thus is of critical importance in clinical diagnostics and food safety. 
For example, proteolytic enzymes, which form one of the largest 
and most diverse enzyme family, have attracted significant attention 
due to their physiological involvement in all life functions [4]. 
Proteases are tightly regulated by complex endogenous pathways 
under physiological conditions [5], however their dysregulation  
can result in the progression of diseases such as Alzheimer’s [6], 
Parkinson’s [7], pulmonary emphysema [8], cardiac disease [9], 
fibrinolysis [10], thrombosis [11], and impaired mitochondrial 
function [12]. Myeloblastin (proteinase 3), a serine protease, is also 
elevated in the urine of patients with diabetic kidney disease, 
caused by endothelial dysfunction and glomerular inflammation 
[13]. There is also growing evidence that suggests a link between 
protease activity and infections of the gastrointestinal tract [14] and 
infected wounds [15]. Similarly, an elevation of proteases can reveal 
diseases in animals, i.e. increased protease activity in cow milk can 
be an indication of bovine mastitis caused by microorganisms such 
as Staphylococcus aureus and Streptococcus uberis [16]. Proteases 
produced by foodborne bacteria via contaminated meat and dairy 
products can lead to rancidity, and decreased shelf life and quality 
of food products [17]. Therefore, proteolytic enzymes can be  
considered as an important biomarker of disease, bacterial infection 
and contamination. Early detection of the proteolytic biomarker 
can ultimately allow clinical diagnosis and intervention, resulting in 
an improved prognosis, treatment and monitoring of human and 
animal health. In the food production industry, identification    
of proteases can also provide an early indication of bacterial 
contamination in food, thus eliminating non-compliance at the early 
stage of the food chain, ensuring food safety, quality and protection 
of consumer health.  
Widely exploited methods for the detection of enzyme biomarkers 
(e.g. protease) in clinical and veterinary samples include two- 
dimensional (2D) gel electrophoresis [18], biochemical and 
immunological assays [19, 20], and mass spectrometry [21]. Recently, 
research has focused on the use of nanotechnology to provide rapid 
sensing of enzymes as biomarkers of infectious diseases, i.e. using 
nanocantilever [22], quantum-dots [23], plasmonics-based [24], and 
other surface enhanced-based approaches [25, 26], to overcome 
limitations in terms of labour intensiveness, long analysis time and 
non-conduciveness to point-of-need testing. In particular, enzyme 
mimics or nanozymes, derived from nanomaterials have initiated 
significant curiosity in the fields of biological sensing and bio-medicine. 
These artificial enzymes are designed to imitate the properties of 
natural enzymes by increasing the catalytic rate of reaction. Importantly, 
nanozymes have the potential to overcome the inherent problems 
of natural enzymes, such as poor stability (denature) and high 
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preparation and purification costs. Furthermore, the superiority 
exhibited by nanozymes, including tunability and even switching of 
enzyme-mimicking activity has led to the development of functional 
nanomaterials for bio-sensing applications [27].  
Peroxidases are defined as a group of enzymes that catalyse the 
oxidation of substrates in the presence of hydrogen peroxide (H2O2). 
For instance, horseradish peroxidase enzyme (HRP) is the predominant 
peroxidase enzyme used in enzyme-linked immunosorbent assays 
(ELISAs) for the detection of a multitude of targets including bacterial 
pathogens [28]. Gold nanoparticles (AuNPs) possess weakly bound 
reactive species such as oxygen atoms on their surface, which leads 
to improved peroxidase-mimicking activity over other noble metals 
such as silver, copper, platinum and palladium [29]. This intrinsic 
peroxidase-mimicking activity of AuNPs, when merged with their 
ease of synthesis, biocompatibility and tunability, makes them excellent 
candidates for nanosensor design. Thus, studies have focused on 
the suppression and enhancement of peroxidase-mimicking activity 
of AuNPs for the detection of H2O2, glucose, DNA and heavy metals. 
Functional molecules such as aptamers, DNA, antibodies, as well   
as cystamine and heavy metals have been utilised to tune the 
enzyme-mimicking activity of AuNPs in the design of biological 
sensors [30–33].  
In this work, we present an unusual switchable peroxidase- 
mimicking activity of AuNPs for the detection of protease, which 
plays a significant role in clinical manifestations and food safety. 
Compared to similar methods for the detection of protease enzyme 
utilising AuNPs, the current approach has improved ease-of-use, 
can be carried out in 90 min in a label-free manner, and does not 
require complicated and expensive equipment. For an overview of 
AuNP based platforms for the detection of proteases, see Table S1 
in the Electronic Supplementary Material (ESM). Finally, we have 
also demonstrated the potential applicability of the nanosensor in 
bovine ultra-heat treated (UHT) milk and synthetic human urine 
for the detection of protease, a biomarker indicative of human or 
animal diseases or food spoilage. 
2 Experimental section 
2.1 Reagents and chemicals  
Sodium citrate tribasic dehydrate (HOC(COONa)(CH2COONa)2·2H2O), 
hydrogen tetrachloroaurate (III) (HAuCl4·3H2O), phosphate buffer 
saline (PBS), acetic acid (CH3COOH), sodium acetate (CH3COONa), 
casein (technical grade), sodium chloride (NaCl), hydrogen peroxide 
(H2O2), protease from bovine pancreas (type I, ≥ 5 units/mg solid, 
EC Number 232-642-4), catalase (bovine liver), lipase (Candida 
rugosa), amylase (porcine pancreas), horseradish peroxidase 
enzyme (HRP), hydrochloric acid (HCl) and Surine™ negative urine 
control (certified reference material, used directly with no further 
preparation steps) were purchased from Sigma Aldrich (UK). 
3,3’,5,5’-Tetramethylbenzidine (TMB) was purchased from Thermo 
Fisher Scientific (UK). 0.45 μm filters were purchased from Merck- 
Millipore (Germany). UHT skimmed milk (0.3% fat) was purchased 
from a local supermarket (Tesco).  
2.2 Gold nanoparticle synthesis  
AuNPs (with an average diameter of 13 nm) were synthesised  
by the Turkevich method [34] with minor alterations. In a typical 
experiment, 2.0 mM HAuCl4·3H2O was dissolved in 50 mL de-ionised 
H2O and heated to reflux under constant stirring (t ~ 10 min). 
Sodium citrate (3.5 mM) was quickly injected and the solution was 
removed from the heat upon the color change from translucent 
yellow to wine red. 
2.3 Modification of gold nanoparticle surface with casein  
To 1.0 mL of freshly prepared AuNPs (optical density measured at 
520 nm, OD520 nm = 3.0), 100 μL of 0.1 mg·mL−1 casein prepared in 
0.1 M PBS (pH 7) was added. The solution was incubated overnight 
at room temperature, however it was noted that 60 min incubation 
was sufficient to ensure AuNP stability. The particles were subsequently 
centrifuged at 15,682g for 60 min to remove residual casein and 
re-suspended in 0.1 M PBS buffer (pH 7). The coated particles were 
stored at 4 °C prior to analysis.   
2.4 Determination of Michaelis-Menten parameters 
Bare and casein-AuNPs were incubated with TMB (0-1.0 mM) and 
varying H2O2 concentrations (0.0075%–6.0%) at room temperature 
for 10 min. Absorption values at 370 nm were measured. For further 
information on the calculation of parameters see the ESM. 
2.5 Detection of enzyme using coated AuNP 
In a typical experiment, 0.1 M PBS buffer (pH 7) was used to 
prepare casein-coated AuNPs and protease to assure the enzymatic 
cleavage activity. 100 μL of 44.43 pM coated-AuNP were incubated 
with 50 μL of protease at 37 °C for 60 min. Subsequently, 150 μL 
solution of 1.0 mM TMB/6.0% H2O2 was added and incubated at 
room temperature for 30 min.  
2.6 Detection of protease enzyme using casein modified 
AuNP in UHT milk and urine samples 
Milk was centrifuged at 15,682g for 60 min and filtered using a 0.45 
μm Millipore filter. It was then diluted 1:50 in PBS buffer (0.1 M, 
pH 7.0). Various protease concentrations (0–5 mg·mL−1) were spiked 
into the prepared milk and analysis carried out as above. Protease 
was spiked into urine (used directly with no further preparation) at 
various concentrations (0–5 mg·mL−1) and the assay was carried out 
as above.    
2.7 Instrumentation for characterization  
Optical absorbance spectrophotometry measurements were carried 
out using a Cary 60 spectrophotometer (Agilent Technologies, USA) 
and a Tecan Safire plate reader (Tecan, Switzerland). Particle size 
and zeta potential measurements were carried out using a Zetasizer 
NanoZS (Malvern, UK). An Eppendorf centrifuge model 5415R 
(Germany) was used throughout the experimental development. 
Transmission electron microscopy (TEM) characterization was 
acquired using a FEI Tecnai F20 operated at 200 kV. 
3 Results and discussion  
The working principle of the developed method for the detection of 
enzyme biomarkers is demonstrated in Fig. 1. The method utilises 
AuNPs which exhibit strong peroxidase-mimicking activity, i.e. 
catalysing for the oxidation of 3,3’,5,5’-tetramethylbenzidine (TMB) 
in the presence of H2O2 to generate a blue colored product (3,3’,5,5’- 
tetramethylbenzidine diimine, oxTMB). Casein is a typical substrate 
for protease digestion [35]. Our study revealed for the first time 
that when AuNPs are coated with casein, the strong peroxidase- 
mimicking activity of AuNPs is suppressed. In the presence of a 
protease from bovine pancreas (an endoproteinase, EC Number 
232-642-4), the enzyme catalyses for the degradation of the  
casein layer on the AuNP surface, thereby recovering the strong 
peroxidase-mimicking activity of the AuNPs. The oxidative product 
derived from TMB provides a color indicator, therefore there is no 
requirement for expensive read-out equipment. Because casein can 
be degraded by almost all serine, cysteine, metallo, and aspartic 
proteases [36], the approach developed in this work is therefore 
suitable for the identification of broad, total protease activity. The 
concept also suggests that sequence-specific proteases could also be 
detected if an appropriate protein or peptide substrate is used for 
the coating.     
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Figure 1 Overall scheme demonstrating the switching of peroxidase-mimicking 
activity of casein coated AuNPs for the detection of enzyme biomarkers. (a) AuNPs 
possess the peroxidase-mimicking ability to catalyse the oxidation of TMB in the 
presence of H2O2, resulting in oxTMB which exhibits a blue color and strongly 
absorbs light at 370 and 650 nm. (b) When casein is coated onto the AuNP 
surface, this peroxidase-mimicking activity is suppressed, resulting in a weakened 
absorbance at 370 and 650 nm. (c) In the presence of protease derived from 
bio-fluids or microorganisms, hydrolytic cleavage of the surface shielding layer 
(casein) results in the recovery of the peroxidase-mimicking activity of AuNP. 
The optimal concentration of casein coated onto the AuNP surface 
(average diameter of 13 nm) was determined and particles were 
subsequently incubated with 0.1 mg·mL−1 casein. This concentration 
was sufficient to suppress the peroxidase-mimicking activity of 
AuNPs, as shown by the diminishment of absorption peak at 370 nm 
in the presence of 1.0 mM TMB and 6.0% H2O2 (Fig. S2 in the 
ESM). Coated particles were then centrifuged to remove any 
unbound residues and suspended in phosphate buffer saline (PBS, 
0.1 M, pH 7). In Fig. 2(a), the casein-AuNP conjugates demonstrate 
a peak absorbance at 525 nm. A shift in wavelength was noted    
in comparison to the bare-AuNP (519 nm) which is indicative of 
increased refractive index around the particle surface, caused    
by adsorbed layers of casein [37]. The absorbance ratio at 650 and  
520 nm was calculated to ensure the coated-AuNPs had not aggregated 
as a result of the coating procedure. Calculating this ratio provides 
detail about the level of aggregation as the absorbance values at  
650 nm, which is the typical wavelength shift generated by AuNP 
aggregation, and 520 nm which is the typical wavelength of    
the dispersed, citrate-stabilised AuNPs subsequent to synthesis. A 
higher ratio would indicate AuNP aggregation. It was determined 
that there was no significant difference in the absorbance ratio    
at 650 and 520 nm between the uncoated-AuNPs and casein 
coated-AuNPs (p = 0.42) (Fig. 2(a)). The p-value is the calculated 
probability, e.g. a p-value > 0.05 indicates that the results are not 
statistically significant. To determine the stability of the casein 
coated-AuNPs, they were exposed to a high electrolyte medium  
(Fig. 2(a)). The results demonstrate no statistical difference between 
casein-coated particles in the absence and presence of 2.0 M NaCl 
(p = 0.37). In addition, full width half maximum (FWHM) calculations 
also demonstrated no peak broadening of spectra for casein-coated 
AuNPs in the presence of 2.0 M NaCl (FWHM = 70.60 nm) 
compared to uncoated-AuNPs (FWHM = 70.02 nm). Peak position 
for FWHM measurement was 519 and 525 nm for the uncoated- 
AuNPs and casein-AuNPs, respectively. Thus, this demonstrates that 
the AuNPs were successfully coated with and strongly stabilized by 
casein. Casein contains carboxyl, hydroxyl, and amine functional 
groups which can self-assemble onto the AuNP surface. The casein 
molecule also consists of both polar and non-polar parts which 
renders the molecule both hydrophobic and hydrophilic. The 
hydrophobic polymer blocks tend to adsorb onto the AuNP surface 
(contributing to the stabilisation of the particle), whilst the 
hydrophilic parts of the casein molecule render them dispersible in 
an aqueous solution [38]. This would explain the high stability of 
casein-coated AuNPs observed in the presence of a high electrolyte 
medium. The casein-coated AuNPs can be rapidly produced and 
have good stability and function when stored for at least 4 weeks at 
4 °C in PBS buffer (0.1 M, pH 7).  
Zeta-potential measurements were conducted with the bare- and 
casein-coated AuNPs to determine surface charge (Fig. 2(b)). The 
citrate reduced bare-AuNPs have a zeta-potential of −46.6 ± 2.58 mV. 
In contrast, the casein-AuNPs exhibit a zeta-potential of −19.1 ± 
2.73 mV. Casein micelles are positively charged, containing mixed 
charged regions at pH 7 [39]. This would suggest that casein can 
effectively shield and partially compensate the negative-citrate charges 
on the nanoparticle surface (do not displace), thus effectively 
suppressing the peroxidase-mimicking activity of the AuNPs in the 
presence of TMB/H2O2. Hydrodynamic size of bare AuNPs (13.9 ± 
2.9 nm) and casein-AuNPs (14.4 ± 1.8 nm) was determined using 
dynamic light scattering (DLS) technique. TEM analysis was also 
carried out (Fig. S3 in the ESM). The as-prepared casein-AuNPs 
demonstrate a size diameter of 14.36 ± 3.0 nm, in comparison to the 
bare-AuNP (13.0 ± 2.2 nm).  
AuNPs acting as an artificial nanozyme for the oxidization of 
TMB are evidenced in Fig. 3. Figure 3(a) demonstrates a vivid blue 
color formation due to the peroxidase-mimicking activities of AuNPs 
in the presence of 1.0 mM TMB and 6.0% H2O2. The images also 
provide evidence that AuNPs are required to oxidise TMB, because 
TMB or TMB/6.0% H2O2 solution on its own cannot be converted 
into the oxidized form under the set conditions (thus not exhibiting 
the blue color). Figure 3(b) demonstrates the development of    
the charge-transfer complex absorption peaks at 370 and 650 nm 
for AuNPs in the presence of TMB/H2O2 (purple line), which are 
indicative of TMB oxidisation reaction [40]. AuNPs display a 
plasmonic peak around 520 nm (Fig. 3(b), black line). To the best of 
our knowledge, the peak absorbance at 650 nm has been frequently 
used as a diagnostic peak in previous studies which exploited the 
peroxidase-mimicking property of AuNPs [30–33]. However, chemical 
and physical interferences may have the potential to induce AuNP 
aggregation, particularly in a medium with high electrolyte content, 
resulting in a red-shift of the plasmon peak around 650–700 nm. 
Therefore, the absorption peak at 650 nm, indicative of the oxTMB 
product, is less useful in this approach due to the potential overlap 
of the nanoparticle aggregation peak.  
Furthermore, it is well known that AuNP size and catalytic 
activity is inversely proportional, i.e. increasing AuNP size results 
in decreasing catalytic activity [29]. 
 
Figure 2 (a) UV–Vis analysis (offset for clarity) of uncoated-AuNPs (black) 
and casein-AuNP (blue). Stability analysis was carried out in the presence of 2.0 M 
NaCl, demonstrating no wavelength shift for the coated-AuNPs, indicating 
successful functionalisation. The pink line indicates the full spectrum analysis of 
casein. (b) Zeta-potential of uncoated AuNPs and casein-coated AuNPs. 
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Figure 3 Peroxidase-mimicking activity of AuNPs (concentration of AuNPs = 
44.43 pM). (a) Representative color images demonstrating the catalysed reaction 
of 1.0 mM TMB/6.0% H2O2 solution in the presence and absence of AuNPs.   
(b) UV–Vis spectroscopic analysis of catalysed reaction of TMB/H2O2 in 
the absence (blue curve) and presence of AuNPs (purple curve). The black and 
orange line demonstrates the spectra for bare AuNPs on their own and 1.0 mM 
TMB, respectively. (c) Kinetic analysis of the catalysed reaction for 1.0 mM 
TMB/6.0% H2O2 in the presence of AuNPs (red line) measured at 370 nm. The 
cyan and black line (overlapped) demonstrates the kinetic analysis for TMB and 
TMB/H2O2, respectively, in the absence of AuNPs. All reactions carried out for 
20 min at room temperature. 
In terms of the casein-AuNP nanosensor for protease detection, 
monitoring the absorbance at 650 nm could give rise to false- 
negative or false-positive results. Based on this, we proposed to use 
the peak at 370 nm to quantify the peroxidase-mimicking activity 
of AuNPs which has not been exploited heretofore. The results also 
demonstrate a time-dependent increase in absorbance at 370 nm 
for AuNPs in the presence of TMB/H2O2 (Fig. 3(c), red). This data 
provides important insight into the peroxidase-mimicking activity 
of AuNPs. 
Kinetic analysis was performed by mixing a fixed concentration 
of AuNPs with various concentrations of TMB/H2O2 and monitoring 
TMB oxidation by absorption analysis at 370 nm. As shown in  
Fig. 4(a), the peroxidase-mimicking activity of AuNPs strongly 
depends on H2O2 concentration. The maximal velocity (Vmax) is   
a useful parameter in determining the maximum conversion of 
substrate to product via natural enzyme (i.e. HRP) or nanozyme  
(i.e. AuNP) at the point where the active sites are fully saturated. 
When the H2O2 increases from 0.0075% (which has been already 
included in the commercial TMB solution) to 6.0%, the maximum 
rate of reaction (Vmax) increases accordingly from 4.9 × 10−7 to 4.4 × 
10−6 M·min−1, respectively. More details about the kinetic parameters 
are summarized in Fig. S4 and Table S5 in the ESM. From a practical 
point of view, clinical and veterinary samples may contain a certain 
level of peroxidase enzymes which in turn could potentially interfere 
with the gold nanozyme activity. To understand the potential 
interferences, kinetic analysis was also carried out for HRP enzyme 
as shown in Fig. 4(b). Indeed, HRP can catalyse for the oxidation of  
 
Figure 4 Typical kinetic analysis of (a) AuNPs and (b) HRP enzyme in the 
presence of varying TMB (0–1.0 mM) and H2O2 concentrations (black: 0.0075%, 
red: 1.0%, blue: 2.0%, cyan: 4.0% and pink: 6.0%). Concentration of natural 
enzyme and nanozyme was fixed at 44.43 pM. Samples were analyzed in triplicate 
(n = 3) and standard deviation deduced from this data. Non-linear curve was 
fitted using the Hill equation. 
TMB with a reaction velocity as high as 2.7 × 10−6 M·min−1 at 0.0075% 
H2O2. Interestingly, the activity of HRP decreases by 6.6 times when 
the H2O2 concentration is higher than 0.0075% (i.e. Vmax = 4.2 × 10−7 
at 1.0% H2O2, and this maximum velocity decreases between 1.0% 
and 6.0% H2O2, see Table S5 in the ESM for more details). This is 
contrary to that observed in the case of AuNPs acting as nanozymes. 
This reduced reaction speed is most likely due to enzyme inactivation 
caused by high H2O2 concentrations [41]. Importantly, this finding 
is useful in the tuning of the catalytic response. Thus, to minimize 
potential interference from contaminating peroxidase enzymes in 
clinical and veterinary samples and to promote the nanozyme activity, 
6.0% H2O2 was chosen for use in all experiments hereafter. 
To test the hypothesis that coating the AuNP surface with casein 
results in the suppression of the peroxidase-mimicking activity, the 
following experiments were conducted. Firstly, uncoated-AuNPs 
and casein-AuNPs (at the same concentration of 44.43 pM) were 
mixed with 1.0 mM TMB and 6.0% H2O2 solution and scanning 
kinetic analysis was carried out (Figs. 5(a) and 5(b)). It is evident in 
Fig. 5(a) that bare-AuNPs can catalyse for the oxidation of TMB in 
the presence of H2O2 instantaneously, resulting in the development 
of two distinct peaks at 370 and 650 nm. The reaction demonstrates 
a substantial increase in absorbance at 370 and 650 nm with time, 
which agrees with the results in Fig. 3(c). Conversely, the casein- 
coated AuNPs demonstrate a much lower absorbance at 370 and 
650 nm (Fig. 5(b)). The casein-coated AuNPs demonstrate a nor-
malized absorbance at 370 nm of 0.7 OD, compared to 3.5 OD for 
uncoated particles post incubation at room temperature for 20 min 
(Fig. 5(c)). This result is supported in Fig. 5(d) which demonstrates 
a reduced reaction velocity with the addition of casein layer onto  
the AuNP surface. Importantly, the catalytic activity of casein-coated 
AuNPs not only show suppression of peroxidase-mimicking activity 
at 6.0% H2O2, but also at lower concentrations (down to 0.0075%). 
For the full kinetic analysis of the casein-coated AuNPs in the 
presence of varying TMB and H2O2 concentrations, see the ESM 
(Fig. S4 and Table S5 in the ESM). 
To fully characterize the peroxidase-mimicking activities of 
AuNPs, Michaelis-Menten catalytic parameters were calculated for  
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Figure 5 Spectral analysis demonstrating decreased peroxidase-mimicking 
activity of casein-AuNP (AuNP concentration = 44.43 pM). The spectra at time 
point zero indicates the wavelength of AuNPs prior to addition of TMB/H2O2, 
demonstrating the plasmon peak around 520 nm. Scanning kinetic analysis of  
(a) uncoated-AuNPs and (b) casein-coated AuNPs. (c) Kinetic analysis demonstrating 
suppressed activity of casein-AuNPs (red) and in the presence of 1.0 mM TMB/ 
6.0% H2O2 compared to uncoated-AuNP (black). Values were normalized against 
TMB/H2O2 solution incubated under the same conditions to remove background 
interference. (d) Reaction velocity of uncoated-AuNPs (black) and casein-AuNPs 
(red) over various TMB concentrations (H2O2 concentration fixed at 6.0%). 
Samples analyzed in triplicate (n = 3) and standard deviation deduced from this 
data. Non-linear curve was fitted using the Hill equation. 
uncoated-AuNPs and casein-AuNPs over varying H2O2 concentrations 
(0.0075%–6.0%) (Table S5 in the ESM). As previously discussed, 
we found that HRP had the highest Vmax value at the lowest H2O2 
concentration (0.0075%), which subsequently decreased with 
increasing H2O2 concentration. This indicates that the reaction 
catalysed by HRP is limited by H2O2 concentration, resulting in a 
much lower maximal rate with increasing concentration. Conversely, 
for the uncoated AuNPs, the Vmax increased by one order of magnitude 
with increasing H2O2 concentration up to 6.0%. Between 0.0075% 
and 1.0% H2O2 the Vmax increased at the greatest rate from 4.9 × 10−7 
to 1.2 × 10−6 M·min−1 (2.4 times). The casein coated-AuNPs 
demonstrated a lower Vmax over all H2O2 concentrations in comparison 
to the uncoated-AuNPs, indicating the ability of the coating molecules 
to slow the rate of substrate diffusion to the AuNP surface. 
The Michaelis-Menten constant (KM) was also calculated to provide 
more information on the substrate concentration required for the 
catalysis to occur. The results show a lower KM value for the uncoated- 
and casein coated-AuNPs from 0.0075%–2.0% H2O2, indicating less 
substrate is required for the catalysis to occur at a significant rate, 
compared to HRP enzyme. This lower value indicates a higher affinity 
towards the TMB substrate. For instance, at 2.0% H2O2 concentration 
the uncoated and casein-coated AuNPs reach one half of its maximum 
speed (½Vmax) at a TMB concentration of 1.3 × 10−1 and 1.4 × 10−1 mM, 
respectively (Table S5 in the ESM). This finding is in agreement with 
Drozd and co-workers who found that the type of surface coating 
did not significantly impact the affinity of the AuNPs towards the 
substrate [42]. Conversely, for HRP this value is 1.8 × 10−1 mM at 
2.0% H2O2, demonstrating that a greater concentration of substrate 
is required to reach ½Vmax. However, above 2.0% H2O2 the KM begins 
to decrease for HRP, so to fully understand the differences in the 
reaction rate, the kcat was calculated. The results demonstrate reduced 
catalytic rate of the casein-AuNPs, confirming that the peroxidase- 
mimicking activity had been suppressed in comparison to the 
uncoated-AuNPs over all H2O2 concentrations. In contrast with the 
uncoated-AuNPs, which had increasing catalytic rate with increasing  
H2O2 concentration, the HRP enzyme had a decreased catalytic 
rate above 0.0075% (by 6.6 times). The catalytic efficiency (kcat/KM) of 
HRP correlates with this finding, demonstrating that at 0.0075% 
H2O2 the enzyme can convert more of the substrate it binds into 
product (Fig. 6). Conversely, for uncoated-AuNPs the catalytic 
efficiency increases between 0.0075% and 6.0% H2O2. Interestingly, 
the uncoated-AuNPs have improved catalytic efficiency (up to 13 times 
at their best performance) in comparison to HRP enzyme. The 
casein-coated AuNPs demonstrate a consistent catalytic efficiency 
with increasing H2O2 concentration. From the results it was determined 
that the catalytic yield relative to the uncoated-AuNPs was as little 
as 22.9% for casein-AuNP (i.e. the intrinsic peroxidase-mimicking 
activity of AuNPs was suppressed by up to 77.1%). These results 
demonstrate reduced catalytic efficiency of the casein coated- 
AuNPs due to decreased substrate diffusion onto the AuNP surface, 
caused by adsorbed casein molecules. 
It is hypothesised that the peroxidase-mimicking activity of the 
coated AuNPs could be recovered if the casein shielding layer is 
disrupted. To fully elucidate the effect of enzyme cleavage on the 
peroxidase-mimicking activity of the coated AuNPs, maximum 
absorbance at 370 nm was used to monitor the production of oxTMB 
as a function of enzyme concentration (0–2.0 mg·mL−1). The reaction 
was carried out in 0.1 M PBS buffer (pH 7) for optimal enzyme 
activity. Figure 7(a) demonstrates the colorimetric response generated 
by casein coated-AuNPs in the presence of protease enzyme (enzyme 
activity = 2 U·mg−1). A visible increase in intensity was noted with 
increasing concentration of protease enzyme from 0 to 2.0 mg·mL−1, 
with the lowest concentration easily observed by the naked-eye 
determined at 100 ng·mL−1. Figure 7(b) demonstrates an increase in 
peak absorbance at 370 nm with increasing enzyme concentration 
up to 2.0 mg·mL−1. These findings are reiterated in Fig. 7(c) where 
there is an increase in absorbance at 370 nm with increasing protease 
concentration from 0 to 2.0 mg ·mL−1 (or from 0–10 U·mL−1). Based 
on the linear fitting (R2 = 0.983), the limit of detection (LOD, three 
times the standard deviation of the blank sample, 3σ) of the 
nanosensor was determined as low as 44 ng·mL−1 of protease (or 
equivalent to 2.2 × 10−4 U·mL−1). The sensitivity of the nanozyme 
approach is not strikingly predominant compared to those reported 
previously [24, 25, 43–45], however the assay time and design of 
coating agent warrants improved capabilities beyond that of current 
methods. The majority of the reported methods utilise peptides as 
the enzyme substrates, when, compared to casein which is used in 
the current approach, increases the overall cost of the assay as well 
as the time involved in peptide probe design. For example, peptide 
functionalised-AuNPs require design of specific, cleavable sequence 
 
Figure 6 Comparison of catalytic efficiency of HRP, uncoated AuNPs and 
casein-AuNPs. The reaction was carried out in the presence of 1.0 mM TMB and 
various H2O2 concentrations for 10 min at room temperature. Concentration of 
natural enzyme and nanozyme was fixed at 44.43 pM and absorbance was 
measured at 370 nm. 
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Figure 7 Naked-eye and spectroscopic analysis of casein coated AuNPs with 
increasing concentration of enzyme. (a) Colorimetric response with increasing 
concentration of protease (0–2.0 mg·mL−1, enzyme activity = 5 U·mL−1).      
(b) Absorption spectra for casein-coated AuNPs with increasing concentration   
of protease. (c) Normalised absorbance at 370 nm as a function of protease 
concentration (inset is the linear fitting, R2 = 0.983; standard deviation (σ) was 
calculated from triplicate samples (n = 3)). The results were normalized against 
the mean of three zero values to remove background signal. 
and modification of anchoring group [24, 25, 44, 45]. Other methods 
utilise gelatine and 6-mercaptohexan-1-ol-AuNPs which requires a 
two-step functionalisation approach, including two incubations at 
37 °C and several washing steps. This further complicates and 
extends the preparation of the nanosensors in comparison to the 
casein-AuNPs which require one incubation and one wash prior to 
use (can be achieved within 3 h). The majority of comparable methods 
utilised AuNP aggregation or dispersion as the transduction signal 
[24, 43–45] which requires modification of probe, i.e. thiol groups to 
induce aggregation upon enzyme cleavage of substrate or inclusion 
of terminal cysteines to ensure AuNP stability. The latter method 
required further functionalisation of the AuNP surface with PEG to 
prevent unwanted interactions between cysteines and the enzyme 
[43]. The current nanosensor utilises casein which is inexpensive 
and readily available. As the approach is based on the degradation of 
casein on the AuNP surface and subsequent recovery of peroxidase- 
mimicking activity, there is no further modification of the substrate 
or the surface required. Other methods require fluorescent labelling 
of probe and thus there is added expense in terms of modification 
and need for expensive read-out equipment, which is not conducive 
to on-site analysis [25]. The production of oxTMB provides a visual 
color response, which can be read without the need for expensive 
equipment. The approach requires an initial 60 min incubation step 
between the casein-AuNPs and the sample. This is followed by the 
direct addition of TMB/ H2O2 and a subsequent 30 min incubation 
step. The analysis time of 90 min is also an improvement over 
methods requiring 2 to 6 h [27, 44]. It must also be noted that the 
method developed by Guarise and group is limited by samples 
contaminated by bisthiols, which potentially give rise to false 
negative results and thus may restrict applications [45]. 
We have now obtained evidence that the peroxidase-mimicking 
activity of the casein-coated AuNPs is recovered if the shielding 
layer is disrupted. Clinical and veterinary samples contain different 
enzymes such as proteases, lipases, catalases, amylases, which 
potentially interfere with the degradation of the shielding layer. 
Therefore, to further investigate the selectivity against these natural 
enzymes, the applicability of the casein-AuNP nanosensor for  
the detection of protease biomarker was determined. Figure 8 
demonstrates the cross-reactivity of protease (bovine pancreas), lipase 
(Candida rugosa), catalase (bovine liver) and amylase (porcine 
pancreas) on the degradation of casein layer coated on the AuNP 
surface. While protease shows strong catalytic activity at both low 
and high concentrations (0.1 and 5 U·mL−1), lipase, catalase, and  
 
Figure 8 Cross-reactivity of common enzymes found in clinical and veterinary 
samples with the casein-coated AuNPs.  
amylase do not exhibit any significant interference on the operation 
of the nanozyme nanosensor. Indeed, the relative absorbance value 
at 370 nm generated by these non-target enzymes is lower than the 
baseline level, which is defined as three times the standard deviation 
of the blank sample, 3σ, representing the high selectivity of the 
nanozyme nanosensor system.  
As previously discussed, the detection of enzymes secreted in 
either bio-fluids or alongside microorganism growth can reveal 
infection, inflammation, contamination or disease conditions. Elevated 
amounts of protease in e.g. bovine milk, can provide information 
about microorganism spoilage or mastitis infection. Furthermore, 
protease enzymes are also found in urine of patients with diabetes 
and chronic renal failure. Therefore, various protease concentrations 
were spiked into bovine UHT milk and negative, synthetic human 
urine sample (certified reference material) to demonstrate the 
applicability of the approach. Figure 9(a) demonstrates the normalized 
absorbance at 370 nm as a function of protease concentration spiked 
in UHT milk. The results demonstrate good linearity (R2 = 0.94), 
with a linear range between 1.0 ng·mL−1 and 100 μg·mL−1 (equivalent 
to the enzyme activity of 5 × 10–5–0.5 U·mL−11) and a LOD of 
490 ng·mL−1 (or 2.45 × 10−3 U·mL−1). The concentration of plasmin 
(a serine protease present in bovine milk) is relatively low in 
non-infected cattle. Richardson and Pearce (1981) reported a con-
centration of 0.14–0.73 μg·mL−1 (labelled as green region in Fig. 9(a) 
as a visual guide) of plasmin in raw milk [46]. During an infection 
this concentration has been found to increase by 2.3 times in some 
cases (labelled as pink region, Fig. 9(a)) [47]. Thus, the reference 
levels suggests that our method is fully applicable to bovine mastitis 
detection in milk as the clinically relevant range falls within the 
dynamic range of the approach (490 ng·mL−1–100 μg·mL−1, or 2.45 × 
10−3–0.5 U·mL−1). Figure 9(b) shows the normalized absorbance at 
370 nm as a function of protease concentration spiked in synthetic 
urine. A good linear response was observed (R2 = 0.97), with a wide 
dynamic range 1.0 ng·mL−1–2.0 mg·mL−1 (or 5 × 10−5– 10 U·mL−1), 
as well as a lower LOD of 176 ng·mL−1 (or 8.8 × 10−4 U·mL−1). This 
lower detection limit in the urine sample is likely due to less matrix 
interferences compared to the complex milk matrix. In comparison 
to buffer conditions, the LOD for protease spiked into milk had 
increased by 11 times, or increased by 4 times for protease spiked 
into urine. Urinary serine protease activity has also been shown 
to be elevated in patients with diabetes, with the control group in 
one study displaying extremely low to no detectable level of pro-
tease. Patients with diabetic kidney disease have a measurable 
serine protease concentration of 0.4 to 1.3 μg·mL−1 [48], which is 
significantly narrower than the clinical range of our developed 
nanozyme approach (176 ng·mL−1–2.0 mg·mL−1). Thus, the nanozyme 
nanosensor demonstrates potential applicability as a rapid and 
low-cost screening tool for protease biomarker detection in both 
veterinary and clinical samples. 
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Figure 9 Relationship between normalized absorbance at 370 nm and 
increasing protease concentration spiked into (a) UHT milk (R2 = 0.94) and (b) 
urine (R2 = 0.97), demonstrating potential applications of the biosensor in food 
safety analysis and clinical and veterinary diagnosis of bacterial infections. 
Samples analyzed in triplicate (n = 3) and standard deviation deduced from this 
data. As a visual guide, the green and red labelled regions represent normal and 
disease cases (elevated), respectively. 
4 Conclusion  
In conclusion, we have developed a simple, low-cost and easy- 
to-use nanosensor, based on the switchable peroxidase-mimicking 
activity of plasmonic AuNPs for the detection of proteolytic enzyme 
biomarker presented in urine and milk. Under experimental 
conditions, the peroxidase-mimicking activity of AuNPs was suppressed 
by up to 77.1% via coating with casein. Casein also provided binding 
recognition sites for protease, an enzyme biomarker indicative of 
disease or food spoilage. Without sophisticated and expensive 
read-out equipment, a result can be obtained in 90 min, generating 
a strong blue color, visible by naked-eye and quantifiable by a 
simple colorimetry technique. In buffer conditions, the nanozyme 
nanosensor system can provide a LOD of 44 ng·mL−1. The application 
for the detection of protease spiked in milk and urine samples has 
also been successfully demonstrated with an effective LOD of 490 
and 176 ng·mL−1, respectively, showing great promise as a screening 
tool for food safety and clinical diagnosis.   
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